| Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease (NCT02610231) | Kyowa Kirin Co., Ltd. | 2015-12-01 |
| Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) (NCT02564263) | Merck Sharp & Dohme LLC | 2015-12-01 |
| Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence (NCT02651584) | Braeburn Pharmaceuticals | 2015-12-01 |
| The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor (NCT02702674) | Ain Shams Maternity Hospital | 2015-12-01 |
| Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients (NCT02666430) | Mylan Inc. | 2015-12-01 |
| Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use (NCT01840085) | Integra LifeSciences Corporation | 2015-12-01 |
| Combination Analgesia for Neonatal Circumcision (NCT02990364) | American University of Beirut Medical Center | 2015-12-01 |
| Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza (NCT02612922) | Romark Laboratories L.C. | 2015-12-01 |
| Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC (NCT02504489) | BeyondSpring Pharmaceuticals Inc. | 2015-12-01 |
| Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) (NCT02635789) | Nobelpharma | 2015-12-01 |
| Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo (NCT02585674) | Sanofi | 2015-12-01 |
| Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in Infancy (NCT03683108) | Policlinico Hospital | 2015-12-01 |
| Effect of a Specific Phenolic Compound on Blood Pressure (NCT02628353) | Technological Centre of Nutrition and Health, Spain | 2015-12-01 |
| Intrathecal Morphine for Postoperative Analgesia Following Laparoscopic Bariatric Surgery (NCT02731430) | Assiut University | 2015-12-01 |
| CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis (NCT02074020) | Anthera Pharmaceuticals | 2015-12-01 |
| Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC (NCT02990780) | Shanghai Chest Hospital | 2015-12-01 |
| DS-5565 Phase III Study for Renal Impairment in Japanese Subjects (NCT02607280) | Daiichi Sankyo Co., Ltd. | 2015-12-01 |
| Can Topical Oxygen Therapy (Natrox™) Improve Wound Healing in Diabetic Foot Ulcers? (NCT02599805) | Unity Health Toronto | 2015-12-01 |
| Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex (NCT02634931) | Nobelpharma | 2015-12-01 |
| The Onset Time of Rocuronium in Emergency and Elective Surgery (NCT02634255) | Diskapi Yildirim Beyazit Education and Research Hospital | 2015-12-01 |
| Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy (NCT02967926) | Chulalongkorn University | 2015-12-01 |
| Neurostimulation for Cognitive Rehabilitation in Stroke (NCT02315807) | Federal University of Paraíba | 2015-12-01 |
| Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer (NCT02651610) | Peregrine Pharmaceuticals | 2015-12-01 |
| Treating Bacterial Overgrowth in Parkinson's Disease (NCT02470780) | University of Cincinnati | 2015-12-01 |
| Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides (NCT02625870) | Jiangsu HengRui Medicine Co., Ltd. | 2015-12-01 |
| Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis (NCT02560948) | BioTech Tools S.A. | 2015-12-01 |
| TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma (NCT02630108) | Shanghai Zhongshan Hospital | 2015-12-01 |
| Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection (NCT02651428) | CorMedix Therapeutics | 2015-12-01 |
| Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2) (NCT03072277) | Public Health Foundation of India | 2015-12-01 |
| Effects of an mHealth Web-Based Platform (HappyAir) on Adherence to a Maintenance Program After Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (NCT04479930) | CEU San Pablo University | 2015-12-01 |
| Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) (NCT02563002) | Merck Sharp & Dohme LLC | 2015-11-30 |
| Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study (NCT02614183) | Eli Lilly and Company | 2015-11-30 |
| The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma (NCT02414165) | Tocagen Inc. | 2015-11-30 |
| A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (NCT02565511) | Novartis Pharmaceuticals | 2015-11-30 |
| Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin (NCT02584504) | Sanofi | 2015-11-30 |
| A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura (NCT02614287) | Eli Lilly and Company | 2015-11-30 |
| Evaluation of Galcanezumab in the Prevention of Chronic Migraine (NCT02614261) | Eli Lilly and Company | 2015-11-30 |
| Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris (NCT02566369) | Galderma R&D | 2015-11-30 |
| A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (NCT02489318) | Aragon Pharmaceuticals, Inc. | 2015-11-27 |
| Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis (NCT02632175) | AbbVie | 2015-11-26 |
| Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence (NCT02414425) | University Hospital, Rouen | 2015-11-25 |
| Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia (NCT03566316) | IlDong Pharmaceutical Co Ltd | 2015-11-24 |
| Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) (NCT02493764) | Merck Sharp & Dohme LLC | 2015-11-24 |
| Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection (NCT02491671) | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 2015-11-24 |
| A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults (NCT02582632) | AbbVie | 2015-11-24 |
| Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis (NCT02606760) | Polichem S.A. | 2015-11-23 |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer (NCT01905046) | Alliance for Clinical Trials in Oncology | 2015-11-23 |
| A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma (NCT02339571) | National Cancer Institute (NCI) | 2015-11-23 |
| BAX 855 PK-guided Dosing (NCT02585960) | Baxalta now part of Shire | 2015-11-23 |
| Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis (NCT02477059) | Assistance Publique - Hôpitaux de Paris | 2015-11-20 |
| A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) (NCT02453256) | Hoffmann-La Roche | 2015-11-20 |
| Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults (NCT02603107) | Gilead Sciences | 2015-11-20 |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism (NCT02585713) | Academic and Community Cancer Research United | 2015-11-20 |
| Safety and Tolerability Study of V501 in Japanese Boys (V501-200) (NCT02576054) | Merck Sharp & Dohme LLC | 2015-11-20 |
| Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) (NCT02604407) | Shire | 2015-11-19 |
| Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia (NCT02612311) | TG Therapeutics, Inc. | 2015-11-19 |
| An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS (NCT02531516) | Aragon Pharmaceuticals, Inc. | 2015-11-19 |
| A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus. (NCT02607306) | Novo Nordisk A/S | 2015-11-18 |
| Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA (NCT03172325) | Cinnagen | 2015-11-18 |
| Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults (NCT02605954) | Gilead Sciences | 2015-11-18 |
| Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4 (NCT02473146) | Versailles Hospital | 2015-11-18 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors (NCT02622321) | Hoffmann-La Roche | 2015-11-18 |
| Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study (NCT02594332) | Johannes Gutenberg University Mainz | 2015-11-17 |
| Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis (NCT02595398) | Clearside Biomedical, Inc. | 2015-11-17 |
| Combined Study - Phase 3b MenB Long Term Persistence in Adolescents (NCT02446743) | GlaxoSmithKline | 2015-11-17 |
| A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) (NCT02608476) | Cassiopea SpA | 2015-11-16 |
| Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma (NCT02614534) | Maimónides Biomedical Research Institute of Córdoba | 2015-11-16 |
| 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer (NCT02624518) | Andrei Iagaru | 2015-11-16 |
| Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy (NCT02607800) | Gilead Sciences | 2015-11-16 |
| Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan (NCT03044912) | Buddhist Tzu Chi General Hospital | 2015-11-16 |
| Glutamate for Metabolic Intervention in Coronary Surgery II (NCT02592824) | University Hospital, Linkoeping | 2015-11-15 |
| Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults (NCT02607930) | Gilead Sciences | 2015-11-13 |
| Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type (NCT02446132) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-11-13 |
| Use of Local Intraoperative Steroid in MIS TLIF (NCT03308084) | Rush University Medical Center | 2015-11-13 |
| A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix (NCT02518594) | The George Washington University Biostatistics Center | 2015-11-13 |
| Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up (NCT02549339) | LEO Pharma | 2015-11-13 |
| A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. (NCT02570126) | GlaxoSmithKline | 2015-11-13 |
| A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis (NCT02597933) | Boehringer Ingelheim | 2015-11-12 |
| An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis (NCT02454205) | University of Cape Town | 2015-11-12 |
| A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A (NCT02615691) | Baxalta now part of Shire | 2015-11-12 |
| Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults (NCT02607956) | Gilead Sciences | 2015-11-11 |
| Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy (NCT02607735) | Gilead Sciences | 2015-11-11 |
| Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed (NCT02603120) | Gilead Sciences | 2015-11-11 |
| Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis (NCT02434029) | Dr. Falk Pharma GmbH | 2015-11-11 |
| Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type (NCT02442778) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-11-11 |
| Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies (NCT02600351) | Gilead Sciences | 2015-11-11 |
| Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) (NCT02393859) | Amgen | 2015-11-10 |
| Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery (NCT02506153) | National Cancer Institute (NCI) | 2015-11-10 |
| A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) (NCT02432144) | Ultragenyx Pharmaceutical Inc | 2015-11-10 |
| Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843) (NCT02577003) | Merck Sharp & Dohme LLC | 2015-11-09 |
| Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome (NCT02527200) | Novo Nordisk A/S | 2015-11-09 |
| To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma (NCT02260804) | Celltrion | 2015-11-09 |
| The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania (NCT02533336) | National Institute for Medical Research, Tanzania | 2015-11-09 |
| A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme (NCT05600491) | Sun Yat-sen University | 2015-11-08 |
| Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis (NCT02514577) | Bausch Health Americas, Inc. | 2015-11-07 |
| Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery (NCT02547623) | ICON Bioscience Inc | 2015-11-06 |
| Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) (NCT02504372) | Merck Sharp & Dohme LLC | 2015-11-06 |
| Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Third Trimester Medical Termination of Pregnancy Analgesia : a Randomized Study. (PCEA-IMG) (NCT02563821) | University Hospital, Limoges | 2015-11-05 |
| Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. (NCT03606369) | Instituto Nacional de Cancerologia de Mexico | 2015-11-05 |
| Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis (NCT02515097) | Bausch Health Americas, Inc. | 2015-11-05 |